FREDERICK COENRAAD DEBEER, MD
Osteopathic Medicine in Lexington, KY

License number
Kentucky 26866
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Kentucky 26866
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
License number
Kentucky 26866
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
740 S LIMESTONE, Lexington, KY 40536
Phone
(859) 323-5116
(859) 218-5677

Personal information

See more information about FREDERICK COENRAAD DEBEER at radaris.com
Name
Address
Phone
Frederick Debeer
2043 Von List Way, Lexington, KY 40502
(859) 433-9334
Frederick Debeer
317 Hilltop Ave, Lexington, KY 40508
(859) 323-5821

Professional information

Frederick C Debeer Photo 1

Dr. Frederick C Debeer, Lexington KY - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
740 S Limestone SUITE J525, Lexington 40536
(859) 323-5116 (Phone)
KENTUCKY MEDICAL SERVICES FOUNDATION
740 S Limestone, Lexington 40536
(859) 323-5311 (Phone), (606) 323-1200 (Fax)
Languages:
English
Education:
Residency Hospital
University Of Ky Hospital Chandler Mc


Frederick Coenraad Debeer Photo 2

Frederick Coenraad Debeer, Lexington KY

Specialties:
Internist
Address:
740 S Limestone, Lexington, KY 40508
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine


Frederick Coenraad Debeer Photo 3

Frederick Coenraad Debeer, Lexington KY

Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Rheumatology
Work:
UK Dept of Rheumatology
740 S Limestone St, Lexington, KY 40536
Education:
University Of Pretoria (1971)


Frederick Debeer Photo 4

Compositions And Methods For Detecting And Treating Atherosclerosis

US Patent:
7521198, Apr 21, 2009
Filed:
May 27, 2003
Appl. No.:
10/445320
Inventors:
Nancy R. Webb - Lexington KY, US
Frederick C. DeBeer - Lexington KY, US
Assignee:
University of Kentucky Research Foundation - Lexington KY
International Classification:
G01N 33/573
US Classification:
435 724, 435 74, 435960
Abstract:
Methods for detecting atherosclerotic plaque and quantifying the amount of Group V sPLAin plasma are disclosed. These methods can be used to assess the risk of cardiovascular pathology in a patient.